Article in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 3 citations in OpenAlex.
International journal of molecular sciences · 2020
Review
4 · The record
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
5 authors at 1 institution in 1 country.
Sylvia M KiertscherDivision of Pulmonary and Critical Care, Department of Medicine, David Geffen School of Medicine at UCLA, CHS 37-131, Los Angeles, CA, 90095-1690, USA.
Pallavi R GangalumDivision of Pulmonary and Critical Care, Department of Medicine, David Geffen School of Medicine at UCLA, CHS 37-131, Los Angeles, CA, 90095-1690, USA.
Grace IbrahimDivision of Pulmonary and Critical Care, Department of Medicine, David Geffen School of Medicine at UCLA, CHS 37-131, Los Angeles, CA, 90095-1690, USA.
Donald P TashkinDivision of Pulmonary and Critical Care, Department of Medicine, David Geffen School of Medicine at UCLA, CHS 37-131, Los Angeles, CA, 90095-1690, USA.
Michael D RothDivision of Pulmonary and Critical Care, Department of Medicine, David Geffen School of Medicine at UCLA, CHS 37-131, Los Angeles, CA, 90095-1690, USA. mroth@mednet.ucla.edu.
University of California, Los Angeles · US
Funding
Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Samuel Wheeler French · 1985 to 2026
$134.5M
Virology CoreP30AI028697 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ANTON, PETER A · 1991 to 2018
$39.9M
PULMONARY EFFECTS OF HABITUAL USE OF MARIJUANA AND/ORR01DA003018 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ROTH, MICHAEL D · 1985 to 2010
$2.7M
Marijuana smoke promotes dysfunctional macrophage responses to HIV and pneumoniaR01DA037102 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ROTH, MICHAEL D · 2014 to 2019
AdultFemaleHepatitis B AntibodiesHepatitis B VaccinesHumansImmunity, CellularImmunity, HumoralMaleMarijuana SmokingMiddle AgedProspective StudiesYoung AdultHepatitis B AntibodiesHepatitis B VaccinesDendritic cellsHepatitis B surface antigenHepatitis B vaccineMarijuanaT cellsΔ9-tetrahydrocannabinol
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
A Prospective Study of Humoral and Cellular Immune Responses to Hepatitis B Vaccination in Habitual Marijuana Smokers. · full record | OpenQuestion